AACT Antibodies

Santa Cruz Biotechnology features a diverse variety of AACT Antibodies for research focused on understanding AACT protein functions. AACT Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AACT, or acyl-CoA thioesterase, plays a crucial role in lipid metabolism by hydrolyzing acyl-CoA thioesters, thereby regulating fatty acid availability and influencing energy homeostasis. AACT is essential for maintaining cellular lipid balance and has implications in metabolic disorders and cardiovascular diseases. Understanding AACT function advances research in metabolic pathways and supports the development of therapeutic strategies. Researchers can utilize specific monoclonal antibodies to investigate AACT expression patterns across different tissues and cellular compartments. Studying AACT regulation mechanisms provides valuable insights into lipid metabolism disorders and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for AACT research enable scientists worldwide to advance our understanding of metabolic diseases and contribute to therapeutic developments.